Monoclonal Antibodies-Lecture



Ronald Levy is an American medical doctor and scientist at Stanford University. He specializes in lymphoma, including Non-Hodgkin's Lymphoma, Burkitt's Lymphoma and Hodgkin's Disease His research investigates how the immune system can be harnessed to fight lymphoma. His work has led to the concept that antibodies can be used as personalized anticancer drugs and to the development of an antibody-based drug, Rituxan, that is widely used to treat lymphoma

No comments:
Write comments
Recommended Posts × +